Democrats are making a late-year push on tax and spending increases but have struggled to find a strategy that unites the party. Some of the more ambitious revenue (tax) measures have been eliminated, which is probably good for American business. Ironically, government dysfunction usually is.
Pfizer had a good month. The FDA authorized the company’s Covid-19 vaccine for children as young as 5, while its oral antiviral for already-infected patients demonstrated excellent trial data, following on similarly strong results from a Merck antiviral last month. Meanwhile, the wave of infections associated with the Delta variant appears to have peaked across the nation, although trends vary by region. There appears to be a strong seasonal component underlying the infection statistics. Once we get past the winter cold and flu season it seems reasonable to expect that we will start to put Covid behind us.
Read More